Atomi Financial Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.56M Buy
27,862
+211
+0.8% +$32.4K 0.14% 129
2025
Q4
$4.81M Buy
27,651
+3,912
+16% +$714K 0.14% 116
2025
Q3
$3.42M Buy
23,739
+644
+3% +$78.9K 0.11% 138
2025
Q2
$2.32M Sell
23,095
-2,331
-9% -$178K 0.09% 164
2025
Q1
$1.94M Buy
25,426
+652
+3% +$49.9K 0.09% 174
2024
Q4
$1.71M Buy
24,774
+1,526
+7% +$110K 0.09% 167
2024
Q3
$1.7M Buy
23,248
+314
+1% +$23.2K 0.11% 156
2024
Q2
$1.54M Sell
22,934
-6,330
-22% -$246K 0.11% 145
2024
Q1
$794K Sell
29,264
-86
-0.3% -$2.41K 0.07% 229
2023
Q4
$910K Buy
+29,350
New +$761K 0.13% 147

Other funds holding INSM

Atomi Financial Group's INSM Position: Q1 2026 in Review

Atomi Financial Group increased its Insmed (INSM) stake by 0.76% in Q1 2026, buying an estimated $32.4K and bringing the position to 27,862 shares worth $4.56M. The position accounts for 0.14% of the portfolio, ranked #129.

Atomi Financial Group first reported a position in INSM in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.81M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Atomi Financial Group held 27,862 shares of Insmed worth $4.56M as of Q1 2026.
  • Atomi Financial Group bought 211 Insmed shares in Q1 2026, an estimated $32.4K.
  • Insmed made up 0.14% of Atomi Financial Group's portfolio in Q1 2026, its #129 holding.
  • Atomi Financial Group first reported a position in Insmed in Q4 2023 and has held it in 10 quarters since.
  • Atomi Financial Group's Insmed position peaked at $4.81M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.